483
Kekule Pharma LimitedFDA 483 - Kekule Pharma Limited - March 15, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Kekule Pharma Limited in Sangareddy, Telangana, India, from March 11-15, 2024, revealed a significant lapse in quality control procedures. The firm failed to document, explain, and investigate deviations from established procedures, specifically regarding temperature excursions in a control sample storage room. This indicates a serious concern with the firm's quality management system and its ability to ensure product quality and integrity.
Open in Dashboard
ID · 4930155b-0f5c-4d06-a85e-d8bc2d9dcb9f